Autonomously administering a pharmaceutical agent to an animal. A tag assembly is affixed to an animal. The tag assembly may be an ear tag, although other configurations can be used. The tag assembly has a reservoir that houses a pharmaceutical agent. An actuator and an application mechanism are provided. A control signal is generated responsive to an input, which may be from a sensor associated with the tag assembly or may be from an external circuit located apart from the tag assembly. Receipt of the control signal causes the actuator to apply a force to the reservoir, which in turn induces a flow of the pharmaceutical agent, via the application mechanism, to a body of the animal. The pharmaceutical agent may be topically or intravenously applied. The pharmaceutical may be an insecticide or some other agent. Multiple reservoirs can be provided to dispense the same or different pharmaceutical agents.

Autonomously administering a pharmaceutical agent to an animal. A tag assembly is affixed to an animal. The tag assembly may be an ear tag, although other configurations can be used. The tag assembly has a reservoir that houses a pharmaceutical agent. An actuator and an application mechanism are provided. A control signal is generated responsive to an input, which may be from a sensor associated with the tag assembly or may be from an external circuit located apart from the tag assembly. Receipt of the control signal causes the actuator to apply a force to the reservoir, which in turn induces a flow of the pharmaceutical agent, via the application mechanism, to a body of the animal. The pharmaceutical agent may be topically or intravenously applied. The pharmaceutical may be an insecticide or some other agent. Multiple reservoirs can be provided to dispense the same or different pharmaceutical agents.

Compositions, devices, and methods are disclosed for treating or preventing fungal infection in an animal are provided. The methods involve exposing the animal to one or more volatile organic compounds (VOCs) in a quantity sufficient to inhibit or reduce fungal growth in the animal. Also disclosed is an automated aerosolization unit (AAU) for delivering compositions, such as the disclosed VOCs, to areas, such as habitats, to treat or prevent fungal infections in animals.

Compositions, devices, and methods are disclosed for treating or preventing fungal infection in an animal are provided. The methods involve exposing the animal to one or more volatile organic compounds (VOCs) in a quantity sufficient to inhibit or reduce fungal growth in the animal. Also disclosed is an automated aerosolization unit (AAU) for delivering compositions, such as the disclosed VOCs, to areas, such as habitats, to treat or prevent fungal infections in animals.

Retention devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and at least one reservoir contained within the housing. The at least one reservoir may have an actuation end and a release end and contain at least one drug formulation. A plug may be contained within the at least one reservoir and be moveable from the actuation end toward the release end. The device may also include an actuation system operably connected to the actuation end of the at least one reservoir and configured to drive the at least one drug formulation from the reservoir. The device may also include at least one retention member affixed to the housing and movable between a non-stressed position, a deployment position, and a retention position for retaining the device in an intraluminal location in the subject.

Retention devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and at least one reservoir contained within the housing. The at least one reservoir may have an actuation end and a release end and contain at least one drug formulation. A plug may be contained within the at least one reservoir and be moveable from the actuation end toward the release end. The device may also include an actuation system operably connected to the actuation end of the at least one reservoir and configured to drive the at least one drug formulation from the reservoir. The device may also include at least one retention member affixed to the housing and movable between a non-stressed position, a deployment position, and a retention position for retaining the device in an intraluminal location in the subject.

The invention relates to a dosage projectile for administering an active agent to an animal, the projectile configured to contain an active agent and having a frangible shell adapted to fragment on impact with an animal to deliver the active agent to the animal and produce a plurality of shell fragments associated with the animal after impact to provide a visible mark on the animal.

The invention relates to a dosage projectile for administering an active agent to an animal, the projectile configured to contain an active agent and having a frangible shell adapted to fragment on impact with an animal to deliver the active agent to the animal and produce a plurality of shell fragments associated with the animal after impact to provide a visible mark on the animal.

A needle guard for protecting a human or animal from accidental contact with a needle connected to said needle guard is disclosed. The needle guard comprises a mounting base for the needle, a hinge structure connecting the mounting base to a needle shield, and a needle shield hinge adjacent to the hinge structure and needle shield. The hinge structure is adapted to pivot the needle shield relative to the mounting base from an open position in which the needle shield is separated from the needle, to a closed position in which the needle shield encloses the needle. The needle shield hinge is adapted to pivot the needle shield relative to the hinge structure. A method of manufacturing the needle guard is also disclosed.

A needle guard for protecting a human or animal from accidental contact with a needle connected to said needle guard is disclosed. The needle guard comprises a mounting base for the needle, a hinge structure connecting the mounting base to a needle shield, and a needle shield hinge adjacent to the hinge structure and needle shield. The hinge structure is adapted to pivot the needle shield relative to the mounting base from an open position in which the needle shield is separated from the needle, to a closed position in which the needle shield encloses the needle. The needle shield hinge is adapted to pivot the needle shield relative to the hinge structure. A method of manufacturing the needle guard is also disclosed.